Menu

Visitors To Our Site
UNITED STATES
  39.4%
UNITED KINGDOM
  15.3%
RUSSIAN FEDERATION
  5.2%
FRANCE
  5.1%
ITALY
  3.6%
BOSNIA AND HERZEGOVINA
  3.4%
PORTUGAL
  3.3%
SWEDEN
  2.5%
REPUBLIC OF KOREA
  2.5%
GERMANY
  2.2%
NETHERLANDS
  2.1%
CHINA
  1.9%
GEORGIA
  1.9%
BELGIUM
  1.8%
SLOVENIA
  1.7%


Global Colon CancerAre you interested in joining our Global Colorectal Cancer Community? Please visit Global Colon Cancer.


You are here:  home > news 

News Articles

Please view the latest news articles from across Europe below. Alternatively, filter by news category or search by keyword.

GE Launches Study To Improve Diagnosis Of Early Stage Colon Cancer



A team of scientists at GE Global Research, the technology development arm for the GE (NYSE: GE), has launched a study with Memorial Sloan-Kettering Cancer Center, (MSKCC) one of the world's premier cancer centers, to better understand the early stages of colon cancer. The goal is to yield new insights that improve treatment selection and outcomes for cancer patients in the future.

"Information is one of the best weapons we have in the fight against cancer," said John Burczak, Chief Scientist for Molecular Imaging at GE Global Research. "With colon cancer, we know that not all cases in the early stages of the disease are alike. Some are more aggressive than others. Through the promise of molecular analysis, we can identify those patients at higher risk and help ensure they receive the best possible treatment option."


For more details View the full story here

back

The information provided is for interest only and is not a substitute for professional medical advice. You should not rely on this information to make or refrain from making any decisions. Always obtain independent professional advice for your own particular health situation.
Registration No: 5314195 Registered Office: 92 Palatine Road, London N16 8ST.